Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?
Main Authors: | , |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2014
|
_version_ | 1826307297580679168 |
---|---|
author | Rees, MG Gloyn, A |
author_facet | Rees, MG Gloyn, A |
author_sort | Rees, MG |
collection | OXFORD |
description | |
first_indexed | 2024-03-07T07:00:48Z |
format | Journal article |
id | oxford-uuid:ffb05e09-ac91-45a4-bf96-195523f4d84c |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T07:00:48Z |
publishDate | 2014 |
record_format | dspace |
spelling | oxford-uuid:ffb05e09-ac91-45a4-bf96-195523f4d84c2022-03-27T13:46:49ZSmall molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ffb05e09-ac91-45a4-bf96-195523f4d84cEnglishSymplectic Elements at Oxford2014Rees, MGGloyn, A |
spellingShingle | Rees, MG Gloyn, A Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour? |
title | Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour? |
title_full | Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour? |
title_fullStr | Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour? |
title_full_unstemmed | Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour? |
title_short | Small molecular glucokinase activators: Has another new anti-diabetic therapeutic lost favour? |
title_sort | small molecular glucokinase activators has another new anti diabetic therapeutic lost favour |
work_keys_str_mv | AT reesmg smallmolecularglucokinaseactivatorshasanothernewantidiabetictherapeuticlostfavour AT gloyna smallmolecularglucokinaseactivatorshasanothernewantidiabetictherapeuticlostfavour |